Clinical Trials Directory

Trials / Sponsors / Biofrontera Bioscience GmbH

Biofrontera Bioscience GmbH

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of
Actinic Keratosis, Keratosis, Actinic, Keratosis
Phase 12021-12-01
CompletedStudy to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expand
Actinic Keratoses
Phase 12020-03-05
CompletedSafety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
Basal Cell Carcinoma (BCC)
Phase 32014-01-28
CompletedSafety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy
Actinic Keratosis
Phase 32013-10-01
CompletedEvaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Thera
Actinic Keratosis
Phase 32008-04-01
CompletedEvaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Kerato
Actinic Keratosis
Phase 32007-12-01
CompletedA Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Kerat
Actinic Keratosis
Phase 22006-10-01